BRS3(FM1) - Anti-Inflammatory Signalling Tone
(Calming Excessive Immune Signalling)
1. Mission & Overview
Mission
Keep inflammatory signalling intensity in check so pro-inflammatory transcription, cytokines, and gut-derived immune load do not chronically dominate.
Overview
A diet-actionable control point that helps regulate how intensely inflammatory signals fire across cytokine networks, NF-κB transcription (a master switch for pro-inflammatory gene expression), gut-derived inputs, and lipid-mediator pathways.
- Helps keep pro-inflammatory transcriptional tone in check through NF-κB regulation.
- Limits gut-derived endotoxin spillover into systemic inflammatory signalling — Supporting BRS5.
- Connects dietary antioxidant and fatty-acid context to inflammatory intensity.
2. Primary Biological Effects
↓ NF-kB tone; ↓ pro-inflammatory cytokines; ↑ immune signalling balance
3. Phenome Connections
These outcomes describe translational contexts for the FM as an integrated biological capacity. They are not single-mechanism treatment claims. Biology → Phenome Confidence reflects biological relevance to each outcome — not proof that diet or lifestyle alone will improve it. Evidence Confidence (below Key References) reflects how convincing the attached evidence is for the Biology → Phenome relationship on that row. FM confidence uplift: FM confidence may exceed that of any individual child PM only where multiple PMs converge on the same phenome and the integrated FM biology provides additional biological rationale (biological uplift) beyond the individual mechanisms.
These are three independent scores. They are not combined or averaged. A phenome can have Medium registry evidence while individual mechanism rows show different Biology → Phenome and Evidence scores.
1. Phenome Evidence Confidence (Phenome Registry only)
Question: How convincing is the foundational evidence that this phenome is a valid, well-defined functional construct — and that diet-relevant biology can plausibly connect to it?
Not a roll-up of Biology → Phenome Confidence or Evidence Confidence from Primary Mechanism page rows. Those are scored per mechanism; this score is assigned once per phenome at registry level.
Derived from foundational landmark evidence organised in up to three layers: construct validation, biology→phenome linkage, and nutrition→biology modulation. Each layer may include one or many landmark papers depending on registry review.
2. Biology → Phenome Confidence (Primary Mechanism page §3 rows)
Question: If this PM/FM biology were substantially impaired in isolation, how directly would that phenome be expected to suffer — within BRAIN architecture?
How it is derived: Reviewers read the PM/FM definition and biological function first — initially ignoring attached references and whether dietary intervention studies exist. References are reviewed only when scoring Evidence Confidence (below).
Score levels (the value shown on each row as Biology → Phenome Confidence):
- High — primary biological determinant (e.g. noradrenergic signalling → attention; GABA synthesis → calming tone)
- Medium — major contributory determinant, not the sole driver
- Low–Medium — established but indirect, modulatory, or one integrative step removed
- Low — distal, conditional, or weak biological coupling
“Not dietary treatment efficacy” means this score does not ask whether a diet or supplement treats the phenome. It asks whether the biology itself is architecturally relevant. Limited dietary RCT evidence belongs in Evidence Confidence, not here.
3. Evidence Confidence (Primary Mechanism page §3 rows)
Question: How convincing are the attached Key References on that specific row that this biology actually relates to this phenome?
How it is derived: Assigned after Biology → Phenome Confidence, by reviewing only the references on that PM/FM row. Judges whether refs support the relationship — not just mechanism or phenome in isolation.
- High — strong convergent human evidence directly linking mechanism biology to phenome variation
- Medium — multiple human lines supporting the relationship; may include one bridge study with an inferential step
- Low–Medium — convergent translational stack without direct mechanism↔phenome measurement on the row
- Low — mechanistic or preclinical only; mechanism and phenome supported separately but not bridged
Often equal to or lower than Biology → Phenome Confidence. Can occasionally be higher when outcome evidence is stronger than the mechanism's contributory role.
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Anti-inflammatory signalling tone — NF-κB restraint and gut-derived inflammatory load — may modulate neuroimmune pathways linked to default-mode hyperconnectivity and perseverative thought in anxiety/depression translational framing.
- Key References:
- Evidence Confidence: Low–Medium
- Biology → Phenome Confidence: Low–Medium
- Synthesis: Chronic low-grade inflammatory and LPS-linked neurotransmission disruption intersect depressive anhedonia biology; integrated anti-inflammatory FM capacity may modulate this context through cytokine and transcriptional tone rather than direct antidepressant claims.
- Key References:
- Evidence Confidence: Low
4. Mechanistic Basis (Integrated FM Narrative)
Anti-inflammatory signalling tone emerges from the coordinated interaction of several primary mechanisms and supporting biological pools.
4.1 Core Primary Mechanisms
-
BRS3-FM1-PM1 — NF-kB Signalling Regulation Regulates the NF-κB inflammatory transcription pathway (a master regulator of pro-inflammatory gene expression) that drives cytokine and immune-activation programmes.
-
BRS3-FM1-PM2 — Gut-Derived Inflammatory Signalling Describes inflammatory signalling driven by endotoxin translocation and barrier dysfunction (leakage of bacterial lipopolysaccharide across the gut lining), linking gut ecology to systemic and neural inflammation.
4.2 Integrated Functional Narrative
Together, NF-κB regulation and gut-derived inflammatory signalling operationalise BRS3(FM1) as coordinated anti-inflammatory signalling control.
At the integrated FM level, anti-inflammatory tone depends not only on direct pathway modulation, but also on whether endotoxin burden, antioxidant coverage, and lipid mediator context keep inflammatory signalling from becoming chronically amplified [Mohammad & Thiemermann, 2021; Zelicha et al., 2022; Batey et al., 2024].
4.3 Suboptimal Function & Its Effects
Anti-inflammatory signalling tone may weaken when antioxidant substrate availability becomes chronically inadequate or when habitual EPA/DHA intake fails to support resolution-competent lipid-mediator context.
Low fruit and vegetable intake may reduce BRS3(KC1) — Antioxidant Substrate Availability. Low polyphenol density, poor sulfur-amino-acid and glutathione-building substrate availability, chronic oxidative burden, and ultra-processed patterns displacing antioxidant-rich foods may further amplify inflammatory signalling pressure.
Low omega-3 intake may limit EPA/DHA substrate availability for lipid-mediator pathways. Excessive omega-6 dominance, low oily-fish consumption, poor fatty-acid diversity, and chronic inflammatory load may skew lipid-mediator context away from resolution-competent signalling.
Gut barrier compromise and metabolic endotoxemia may amplify gut-derived inflammatory inputs—see BRS5(FM1) — Gut Barrier Integrity and Immune Interface.
These pressures may impair BRS3-FM1-PM1 — NF-kB Signalling Regulation and weaken BRS3-FM1-PM2 — Gut-Derived Inflammatory Signalling. At the FM level, this may shift BRS3(FM1) toward chronically elevated pro-inflammatory tone.
4.4 Evidence Highlights
Introduction/Summary
The studies below support anti-inflammatory signalling tone as an integrated FM state emerging from coordinated child PM biology — mechanism-qualifying findings that refine framework interpretation, not phenome/outcome science (which belongs in §3).
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Polyphenol-rich dietary-pattern interventions such as the Green Mediterranean Diet report shifts in inflammatory biomarkers consistent with lower pro-inflammatory signalling pressure — supporting pattern-based anti-inflammatory levers rather than single-nutrient dosing for this PM [Zelicha et al., 2022].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Lipopolysaccharide-linked inflammatory signalling is modulated by dietary and postprandial context, linking meal patterns to systemic inflammatory load [Batey et al., 2024].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: When the gut barrier weakens, bacterial fragments such as lipopolysaccharide enter circulation and sustain chronic low-grade inflammation — illustrating gut-derived endotoxin translocation and its inflammatory consequences [Mohammad & Thiemermann, 2021]. Dietary and postprandial context modulates LPS-linked inflammatory responses [Batey et al., 2024].
- Key References:
- Confidence: low-medium
- Evidence Level: mechanistic
- Rationale: Butyrate has anti-inflammatory effects and supports mitochondrial brain energy metabolism — linking gut-derived SCFA biology to this PM's inflammatory load frame [Yunting Li et al., 2024; Cavaliere et al., 2022].
- Key References:
5. Connected Mechanisms
- BRS3-FM2-PM3 - Nrf2-ARE Antioxidant Activation — nrf2-ARE Antioxidant Activation
- BRS3-FM2-PM4 - ROS Generation vs Clearance Balance — rOS Generation vs Clearance Balance
- BRS3-FM3-PM7 - Cytokine Network Modulation — cytokine Network Modulation
- BRS5-FM1-PM1 — Gut Barrier / Tight Junction Integrity — gut Barrier / Tight Junction Integrity
- BRS5(FM1) — Gut Barrier Integrity and Immune Interface — Upstream NF-κB transcriptional control
- BRS6-FM1-PM2 — Glycaemic Variability Regulation — Insulin Sensitivity & Glucose Disposal
6. References
- Serhan and Petasis (2011) — Resolvins and Protectins in Inflammation Resolution
- Ferguson et al. (2014) — Omega‐3 PUFA Supplementation and the Response to Evoked Endotoxemia in Healthy Volunteers
- Batey et al. (2024) — Understanding Implications for Depression
- Zelicha et al. (2022) — DIRECT PLUS Randomized Controlled Trial
- Mohammad & Thiemermann (2021) — Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
- Marsland et al. (2017) — Systemic Inflammation and Resting State Connectivity of the Default Mode Network
- Song et al. (2023) — A Fatal Blow in Depression